• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchIntensity Therapeutics
    Picture of Intensity Therapeutics logo

    INTS — Intensity Therapeutics News Story

    $3.250.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro CapSucker Stock
    • Market Cap
      $10.61m
    • Enterprise Value
      $1.08m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • INTS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    INTS Dividends
    All News

    NASDAQ RESUMED AT 09:00 AM

    Picture of Intensity Therapeutics logoIntensity Therapeutics
    19/02/2026 14:00
    NASDAQ RESUMED  INTS.O  AT 09:00 AM
    

    Recent news on Intensity Therapeutics

    See all news
    • Intensity Therapeutics Q2 net loss widens as R&D costs rise

      11/08/2026 12:38
    • Brief: Intensity Therapeutics Q2 Operating Income USD -3.084 Million

      11/08/2026 12:31
    • Intensity Therapeutics Q1 net loss narrows on lower R&D costs

      07/05/2026 22:00
    • Brief: Intensity Therapeutics Q1 Operating Income USD -2.526 Million

      07/05/2026 21:07
    • Brief: Intensity Therapeutics Inc - Increases ATM Offering Capacity To $60 Million On March 23, 2026 - SEC Filing

      23/03/2026 20:48

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.